Cerus | CERS - Cost Of Sales


Cerus reported $23.42M in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Cerus USD 23.42M 3.61M Dec/2024
GRIFOLS EUR 1.29B 163.12M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Neogen USD 118.01M 3.79M Sep/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
Rockwell Medical USD 21.28M 1.67M Jun/2024
STAAR Surgical USD 14.06M 2.8M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Utah Medical Products USD 4.2M 50K Sep/2024